Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic Treatment

NACompletedINTERVENTIONAL
Enrollment

2,024

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Coronary Occlusion/ThrombosisPeptic Ulcer Hemorrhage
Interventions
OTHER

Screening for risk factors for ulcer bleeding

"Following PCI the patients fill out a questionnaire to assess the risk factors for ulcer bleeding.We randomise between:~1. screening and risk assessment~2. control group~All screened patients, who fulfil the criteria for having a moderate to high risk of ulcer bleeding will be sent written information about risk factors and the purpose of the PPI prophylaxis. They will be recommended PPI prophylaxis (Pantoprazole), as long as they are being treated with low-dose aspirin and clopidogrel.~Patients in the screening group, who are already on PPI treatment is recommended to change to Pantoprazole.~Definition of risk of ulcer bleeding: The table below will be used for screening. Patients scoring ≥ 2 points will receive PPI prophylaxis.~points: Age: \< 60: 0; 60-69: 1; 70-79: 2; \>=80: 3 \_\_\_ Dyspepsia: 1 \_\_\_ Uncomplicated ulcer: 2 \_\_\_ Complicated ulcer 3 \_\_\_ NSAID 2 \_\_\_ Steroids 2 \_\_\_ SSRI 2 \_\_\_ Anticoagulant Tx 2 \_\_\_"

Trial Locations (1)

5000

Odense University Hospital, Odense

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Danish Heart Foundation

OTHER

collaborator

Region of Southern Denmark

OTHER

lead

Odense University Hospital

OTHER